HLA-DQA2
HLA class II histocompatibility antigen, DQ alpha 2 chain
Also known as: DQA2_HUMAN, HLA-DXA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01906
- Gene
- HLA-DQA2
- Ensembl
- ENSG00000237541
- Chromosome
- 6
- Canonical length
- 255 aa
- Protein class
- Human disease related genes, Predicted membrane proteins
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene belongs to the HLA class II alpha chain family. The encoded protein forms a heterodimer with a class II beta chain. It is located in intracellular vesicles and plays a central role in the peptide loading of MHC class II molecules by helping to release the CLIP molecule from the peptide binding site. Class II molecules are expressed in antigen presenting cells (B lymphocytes, dendritic cells, macrophages) and are used to present antigenic peptides on the cell surface to be recognized by CD4 T-cells. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
255 residues, UniProt reviewed canonical sequence.
>P01906|HLA-DQA2
1 MILNKALLLG ALALTAVMSP CGGEDIVADH VASYGVNFYQ SHGPSGQYTH EFDGDEEFYV
61 DLETKETVWQ LPMFSKFISF DPQSALRNMA VGKHTLEFMM RQSNSTAATN EVPEVTVFSK
121 FPVTLGQPNT LICLVDNIFP PVVNITWLSN GHSVTEGVSE TSFLSKSDHS FFKISYLTFL
181 PSADEIYDCK VEHWGLDEPL LKHWEPEIPA PMSELTETLV CALGLSVGLM GIVVGTVFII
241 QGLRSVGASR HQGLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HLA-DQA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- spleen: 26 nTPM
- lung: 21 nTPM
- small intestine: 12 nTPM
- adipose tissue: 11 nTPM
- skin: 8.5 nTPM
- blood vessel: 7.8 nTPM
Single-cell type
- cdc: 63 nCPM
- pdcs: 21 nCPM
- macrophages: 13 nCPM
- monocytes: 12 nCPM
- b-cells: 9 nCPM
- endometrial secretory cells: 8.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.6
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.27
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
OntologyGO
Biological processes
- adaptive immune response
- antigen processing and presentation of exogenous peptide antigen via MHC class II
- immune response
- peptide antigen assembly with MHC class II protein complex
- positive regulation of immune response
- positive regulation of T cell activation
Molecular functions
Cellular components
- clathrin-coated endocytic vesicle membrane
- endocytic vesicle membrane
- ER to Golgi transport vesicle membrane
- Golgi membrane
- late endosome membrane
- lumenal side of endoplasmic reticulum membrane
- lysosomal membrane
- MHC class II protein complex
- plasma membrane
- trans-Golgi network membrane
- transport vesicle membrane
Protein domainsUniProt · Pfam · InterPro
- MHC class II, alpha chain, N-terminal
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- MHC class II, alpha/beta chain, N-terminal
- Immunoglobulin-like domain superfamily
- Major Histocompatibility Complex/Immunoglobulin
- Class II histocompatibility antigen, alpha domain
- Immunoglobulin C1-set domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HLA-DQA2 as an antibody target. Whether an autoantibody or antibody against HLA-DQA2 could matter depends on whether native HLA-DQA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HLA-DQA2 is annotated at the cell surface, where native HLA-DQA2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HLA-DQA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...